hLife
Издатель: Elsevier · ISSN 2949-9283 · 16 статей
-
Beyond canonical immune checkpoints: MMRN1 establishes a glycoimmune stemness axis in AML
Publication date: September 2026 Source: Cell Investigation, Volume 2, Issue 3 Author(s): Xiangguo Shi
-
Beyond ADCs: Antibody-encapsulated drug for targeted cancer therapy
Publication date: September 2026 Source: Cell Investigation, Volume 2, Issue 3 Author(s): Linrong Li, Armando Giuliano, Qiang Sun, Xiaojiang Cui, Yuan Yuan
-
Development and validation of a prognostic nomogram based on clinicopathological characteristics for renal cell carcinoma in patients aged 30 years or younger: A 12-year single-centre study
Publication date: September 2026 Source: Cell Investigation, Volume 2, Issue 3 Author(s): Zhi Li, Changwei Shi, Manwei Huang, Yibo Chen, Jialong Song, Cheng Peng, Deqiang Lv, Xu Bai, Hau Chun Khoo, Xin Ma, Peng Zhang, Junnan Xu, Qingbo Huang
-
Reduced IL10 expression in diminished ovarian reserve and receptor-dependent IL-10 responses in granulosa cell models
Publication date: September 2026 Source: Cell Investigation, Volume 2, Issue 3 Author(s): Yiman Fu, Yannuan Chen, Zhiguang Chang
-
Clonal hematopoiesis as a context-dependent modifier of organ-specific disease: Evidence, mechanisms, and translational boundaries
Publication date: September 2026 Source: Cell Investigation, Volume 2, Issue 3 Author(s): Bulang Tang, Yihe Kuai, Zhitao Ye, Xuan Zhao, Chuqing Fan, Meiqi Huang, Yucheng Luo, Changzheng Li
-
Association between obstructive sleep apnea and erectile dysfunction and changes in erectile function following CPAP therapy: A systematic review
Publication date: September 2026 Source: Cell Investigation, Volume 2, Issue 3 Author(s): Hongliang Jiang, Yiwen Zhou, Pengfei Zheng, Zezhong Mou, Shanwen Chen, Shanhua Mao
-
From bone marrow failure to myeloid malignancies: Multi-dimensional mechanistic insights and therapeutic perspectives
Publication date: September 2026 Source: Cell Investigation, Volume 2, Issue 3 Author(s): Jicheng Ding, Yimeng Jiang, Zhengrong Xu, Ying Zheng, Lili Pan
-
The emerging role of aging in tumorigenesis
Publication date: September 2026 Source: Cell Investigation, Volume 2, Issue 3 Author(s): Xiaofen Wu, Hui Wang, Yuguo Liu, Ping Hu
-
Expert consensus on adjunctive therapy and dietary intervention of medicinal and food homologous substances for colorectal cancer (2026 Edition)
Publication date: September 2026 Source: Cell Investigation, Volume 2, Issue 3 Author(s): Mingxing Wang, Xiaonan Zhang, Yaning Cao, Yuru Wang, Xiaojing Xu, Mingxuan Yang, Yi Zhong
-
Corrigendum regarding duplicated and format-inaccurate references in previously published articles in Volume 1—Volume 2
Publication date: September 2026 Source: Cell Investigation, Volume 2, Issue 3 Author(s):
-
Corrigendum to “circLPAR3 promotes the progression of papillary thyroid carcinoma through the IGF2BP2/TRIM55 axis” [Cell Investigation 2 (2026) 100077]
Publication date: September 2026 Source: Cell Investigation, Volume 2, Issue 3 Author(s): Kaiqing Liu, Juncheng Tong, Kefeng Lei, Ahmed Abdelbaset-Ismail, Junjie Liu, Xina Xie, Bing Hu, Zesong Li, Aifa Tang
-
Corrigendum to “Lycium barbarum polysaccharide suppresses uridine induced malignant progression of lung adenocarcinoma via UPP1 regulation” [Cell Investigation 2 (2026) 100045]
Publication date: September 2026 Source: Cell Investigation, Volume 2, Issue 3 Author(s): Jingqin Chen, Qiuyin Huang, Congyan Hou, Jiao Liang, Jieying Guan, Sirou Chen, Xinyuan Wang, Ren Zhang, Yanli He
-
Corrigendum to “Development and validation of a prognostic nomogram based on clinicopathological characteristics for renal cell carcinoma in patients aged 30 years or younger: A 12-year single-centre study” [Cell Investigation 2 (2026) 100085]
Publication date: September 2026 Source: Cell Investigation, Volume 2, Issue 3 Author(s): Zhi Li, Changwei Shi, Manwei Huang, Yibo Chen, Jialong Song, Cheng Peng, Deqiang Lv, Xu Bai, Hau Chun Khoo, Xin Ma, Peng Zhang, Junnan Xu, Qingbo Huang
-
Garmultinone A synergizes with oncolytic virus to induce tumor cell apoptosis through YAP1 degradation
Publication date: December 2026 Source: Cell Investigation, Volume 2, Issue 4 Author(s): Yuqing Yang, Fang Wang, Lihui He, Ruxi Chen, Yuequan Zeng, Xi Shen, Yuqin Li, Jun Liu, Xi Lin, Kehong Zheng, Yubo Zhang, Haipeng Zhang
-
Affibody-based approaches as potential therapeutics for breast cancer: mechanisms, applications, and future perspectives
Publication date: December 2026 Source: Cell Investigation, Volume 2, Issue 4 Author(s): Ru Yao, Keghon Kasparian, Yidong Zhou, Qiang Sun, Armando Giuliano, Bo Pan, Shengxi Chen, Xiaojiang Cui
-
Corrigendum to “Synthetic cell model reveals the coupling of ecDNA maintenance and genomic instability” [Cell Investig. 2 (2026) 100076]
Publication date: December 2026 Source: Cell Investigation, Volume 2, Issue 4 Author(s): Fengshan Huang, Jiawen Yang, Jiaqi Zhou, Songlin Du, Suili Hu, Junwei Lai, Yang Zhang, Lingyu Qiu, Qingmei Zhang, Kewei Xu, Yajing Xu, Jianxun...